Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,160 | 182,574 | 243,592 | 225,449 | 175,380 |
| Receivables | 192,972 | 190,101 | 210,214 | 213,908 | 202,658 |
| Inventories | 100,297 | 102,723 | 96,882 | 88,023 | 72,362 |
| Other current assets | 80,465 | 120,203 | 67,451 | 80,484 | 50,693 |
| TOTAL | $552,894 | $595,601 | $618,139 | $607,864 | $501,093 |
| Non-Current Assets | |||||
| PPE Net | 752,657 | 863,744 | 837,246 | 748,793 | 534,745 |
| Intangibles | 319,674 | 661,815 | 593,678 | 1,269,445 | 1,279,513 |
| Other Non-Current Assets | 108,148 | 82,933 | 92,350 | 179,435 | 242,193 |
| TOTAL | $1,180,479 | $1,608,492 | $1,523,274 | $2,197,673 | $2,056,451 |
| Total Assets | $1,733,373 | $2,204,093 | $2,141,413 | $2,805,537 | $2,557,544 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,582 | 35,413 | 35,452 | 25,051 | 24,970 |
| Accounts payable and accrued liabilities | 30,627 | 31,218 | 40,517 | 36,715 | 28,223 |
| Accrued Expenses | 108,287 | 94,046 | 115,611 | 114,725 | 83,642 |
| Other current liabilities | 20,095 | 15,219 | 22,711 | 23,268 | 25,632 |
| TOTAL | $259,780 | $249,773 | $300,998 | $302,528 | $259,331 |
| Non-Current Liabilities | |||||
| Long Term Debt | 670,270 | 457,419 | 479,880 | 484,998 | 547,084 |
| Deferred Revenues | 66,905 | 71,114 | 86,707 | 102,021 | 93,197 |
| Other Non-Current Liabilities | 120,044 | 124,916 | 119,514 | 157,074 | 155,918 |
| TOTAL | $784,866 | $580,496 | $598,707 | $642,542 | $703,002 |
| Total Liabilities | $1,044,646 | $830,269 | $899,705 | $945,070 | $962,333 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,478 | 65,888 | 66,790 | 68,176 | 66,933 |
| Common Shares | 775 | 771 | 766 | 754 | 734 |
| Retained earnings | -575,162 | -238,493 | -352,934 | 177,529 | 23,123 |
| Other shareholders' equity | 35,240 | 44,091 | 3,845 | 85,187 | 21,216 |
| TOTAL | $688,727 | $1,373,824 | $1,241,708 | $1,860,467 | $1,595,211 |
| Total Liabilities And Equity | $1,733,373 | $2,204,093 | $2,141,413 | $2,805,537 | $2,557,544 |